EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic

Isaac Ravi Brenner, Kit N Simpson, Clare F Flanagan, Tyra Dark, Mary Dooley, Allison L Agwu, Wei Li Adeline Koay iD, Kenneth A Freedberg iD, Andrea L Ciaranello iD, Anne M Neilan iD

Journal of the Pediatric Infectious Diseases Society · 2024

DOI: 10.1093/jpids/piad102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Isaac Ravi Brenner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, COVID-19, HIV Infections, Telemedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During the COVID-19 pandemic, many US youth with HIV (YHIV) used telehealth services; others experienced disruptions in clinic and antiretroviral therapy (ART) access.

Methods

Using the Cost-effectiveness of Preventing AIDS Complications (CEPAC)-Adolescent HIV microsimulation model, we evaluated 3 scenarios: 1) Clinic: in-person care; 2) Telehealth: virtual visits, without CD4 or viral load monitoring for 12 months, followed by return to usual care; and 3) Interruption: complete care interruption with no ART access or laboratory monitoring for 6 months (maximum clinic closure time), followed by return to usual care for 80%. We assigned higher 1-year retention (87% vs 80%) and lower cost/visit ($49 vs $56) for Telehealth vs Clinic. We modeled 2 YHIV cohorts with non-perinatal (YNPHIV) and perinatal (YPHIV) HIV, which differed by mean age (22 vs 16 years), sex at birth (85% vs 47% male), starting CD4 count (527/μL vs 635/μL), ART, mortality, and HIV-related costs. We projected life months (LMs) and costs/100 YHIV over 10 years.

Results

Over 10 years, LMs in Clinic and Telehealth would be similar (YNPHIV: 11 350 vs 11 360 LMs; YPHIV: 11 680 LMs for both strategies); costs would be $0.3M (YNPHIV) and $0.4M (YPHIV) more for Telehealth than Clinic. Interruption would be less effective (YNPHIV: 11 230 LMs; YPHIV: 11 620 LMs) and less costly (YNPHIV: $1.3M less; YPHIV: $0.2M less) than Clinic. Higher retention in Telehealth led to increased ART use and thus higher costs.

Conclusions

Telehealth could be as effective as in-person care for some YHIV, at slightly increased cost. Short interruptions to ART and laboratory monitoring may have negative long-term clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsCOVID-19HIV InfectionsTelemedicinePregnancyFemaleInfant, NewbornHumansMaleAdolescentYoung AdultUnited StatesPandemics

Stichwörter der Autor:innen

COVID-19HIVadolescents and young adultstelehealthyouth

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Healthcare Leadership and Management, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Behavioral Sciences and Social Medicine, Center for Translational Behavioral Sciences, Florida State University College of Medicine, Tallahassee, Florida, USA.
  • Division of Infectious Diseases, Departments of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Infectious Diseases, Children's National Hospital, Washington, District of Columbia, USA.
  • School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.

ORCID-Profile: Wei Li Adeline Koay, Kenneth A Freedberg, Andrea L Ciaranello, Anne M Neilan

Förderung

  • NICHD NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • Eunice Kennedy Shriver National Institute for Child Health and Human Development
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Brenner, I. R., Simpson, K. N., Flanagan, C. F., Dark, T., Dooley, M., Agwu, A. L., Koay, W. L. A., Freedberg, K. A., Ciaranello, A. L., & Neilan, A. M. (2024). Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piad102

Vancouver

Brenner IR, Simpson KN, Flanagan CF, Dark T, Dooley M, Agwu AL, et al. Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piad102

BibTeX
@article{Brenner2024,
  author = {Brenner, Isaac Ravi and Simpson, Kit N and Flanagan, Clare F and Dark, Tyra and Dooley, Mary and Agwu, Allison L and Koay, Wei Li Adeline and Freedberg, Kenneth A and Ciaranello, Andrea L and Neilan, Anne M},
  title = {Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  doi = {10.1093/jpids/piad102}
}
Kostenlos starten →